» Articles » PMID: 37568379

Exploring Microbiota Diversity in Cervical Lesion Progression and HPV Infection Through 16S RRNA Gene Metagenomic Sequencing

Overview
Journal J Clin Med
Specialty General Medicine
Date 2023 Aug 12
PMID 37568379
Authors
Affiliations
Soon will be listed here.
Abstract

(1) Background: Cervical cancer is a significant health concern, with the main cause being persistent infection with high-risk Human Papillomavirus (hrHPV). There is still no evidence for why viral persistence occurs in some women, but recent studies have revealed the interplay between cervical microbiota and hrHPV. This research aimed to characterize the cervicovaginal microbiota in cervical lesion progression and HPV infection status. (2) Methods: This study included 85 cervical specimens from women from the north-eastern region of Romania. DNA was isolated from cervical secretion for HPV genotyping and 16S ribosomal RNA gene NGS sequencing. (3) Results: Our study revealed a distinct pattern within the studied group when considering Lactobacillus species, which differs from findings reported in other populations. Specifically, the presence of coupled with the absence of alongside spp., spp., and spp. could serve as defining factors for severe cervical lesions. The results also showed a significant association between microbiota diversity, HPV infection, and cervical lesion progression. (4) Conclusions: As the microbiota profile seems to vary among different populations and individuals, a deeper comprehension of its composition has the potential to develop personalized detection and treatment approaches for cervical dysplasia and cancer.

Citing Articles

Associations of the gut, cervical, and vaginal microbiota with cervical cancer: a systematic review and meta-analysis.

Wen Q, Wang S, Min Y, Liu X, Fang J, Lang J BMC Womens Health. 2025; 25(1):65.

PMID: 39955550 PMC: 11829412. DOI: 10.1186/s12905-025-03599-1.


Understanding the vaginal microbiome among women with different genotypes of human papillomavirus infection in remote Andaman islands.

Parvez R, Vijayakumar S, Vins A, Ramaiah S, Anbarasu A, Biswas L Front Cell Infect Microbiol. 2025; 14:1486166.

PMID: 39882346 PMC: 11775162. DOI: 10.3389/fcimb.2024.1486166.


Human Papillomavirus Infections and the Role Played by Cervical and Cervico-Vaginal Microbiota-Evidence from Next-Generation Sequencing Studies.

Glowienka-Stodolak M, Baginska-Drabiuk K, Szubert S, Hennig E, Horala A, Dabrowska M Cancers (Basel). 2024; 16(2).

PMID: 38254888 PMC: 10814012. DOI: 10.3390/cancers16020399.

References
1.
Anton G, Peltecu G, Socolov D, Cornitescu F, Bleotu C, Sgarbura Z . Type-specific human papillomavirus detection in cervical smears in Romania. APMIS. 2010; 119(1):1-9. PMC: 3132448. DOI: 10.1111/j.1600-0463.2010.02641.x. View

2.
Bradshaw C, Morton A, Hocking J, Garland S, Morris M, Moss L . High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis. 2006; 193(11):1478-86. DOI: 10.1086/503780. View

3.
Lee J, Lee S, Lee H, Song Y, Lee K, Han M . Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PLoS One. 2013; 8(5):e63514. PMC: 3661536. DOI: 10.1371/journal.pone.0063514. View

4.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

5.
Bradshaw C, Walker J, Fairley C, Chen M, Tabrizi S, Donovan B . Prevalent and incident bacterial vaginosis are associated with sexual and contraceptive behaviours in young Australian women. PLoS One. 2013; 8(3):e57688. PMC: 3589386. DOI: 10.1371/journal.pone.0057688. View